Form4.ai tracks every SEC insider trade in real time. See every CRBP insider filing with a free account — no card.
See every CRBP insider filing — free account, no card.
Free accountCorbus Pharmaceuticals Holdings, Inc. (CRBP) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $25K, and 4 sales totalling $2.1M. Most recent filing: Nov. 2, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 2, 2026 SEC filing | Cormorant Asset Management, LP Insider | Sold | $1,742,755 | — |
| Sep 15, 2026 SEC filing | Ben Yong Director | Sold | $15,683 | — |
| Aug 17, 2026 SEC filing | Nicacio Leonardo Viana Chief Medical Officer | Grant / award | — | — |
Create a free account to see all 6 CRBP filings from the last 90 days. No card needed.
Create free accountWant CRBP insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.